Main content
Gavegnano Drug Discovery Program in the News
- Video for baricitinib discovery
- Interview for baricitinib discovery for COVID-19 and viral infections, and building the interface of drug discovery across the Emory College and Emory School of Medicine
- Interview and piece about Dr. Gavegnano's PhD discovery, patent and baricitinib for COVID-19 and viral infections
- Interview and piece about Dr. Gavegnano's PhD discovery, bench-to-bedside success for baricitinib for COVID-19 and viral infections (“Health is Everything”)
- Interview and piece about PhD discovery, bench-to-bedside success for baricitinib for COVID-19 and viral infections, and the collaborative partnership with the Veteran’s Affairs Medical Center in this achievement: PhD discovery, bench-to-bedside success for baricitinib for COVID-19 and viral infections
- “‘Drug discovery’ courses showcase the bench-to-bedside process”. Interview and piece about how Dr. Gavegnano is building bench-to-bedside training and infrastructure between Emory College and Emory School of Medicine, towards exposing students to the process of drug discovery and saving lives
- Interview, written and video piece about Dr. Gavegnano's invention of baricitinib for viral infections, repurposed to save lives
- Atlanta Celebration for Inventors-piece about Gavegnano and saving lives with baricitinib (COVID-19 and other viral infections)
- Emory Newswire and A.P. press release for baricitinib and COVID-19, including interview and piece about Gavegnano role in this live-saving discovery
- The New York Times: COVID-19 drug discovery and baricitinib including interview with Gavegnano
- Academic Medical Education: Video and interview of Gavegnano for how Jak inhibitors including baricitinib can ameliorate viral infections in the CNS (including HIV-1)
- The Baltimore Sun: COVID-19 drug discovery and baricitinib including interview with Gavegnano
- Forbes (India): COVID-19 drug discovery and baricitinib including interview with Gavegnano
- International AIDS Society: Why Curing HIV-1 may be like Curing Cancer; Gavegnano interviewed
- International A.P. press release: Selective suppression of inflammation could deplete HIV and control HIV activation; interview with Gavegnano
- Case Western Reserve “The Daily” press release and interview with Gavegnano
- The HIV-1 Gut Reservoir and Immunity: Emory School of Medicine: Discussion of new MPI enrolled study including Gavegnano (MPI)